Status:
UNKNOWN
Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs
Lead Sponsor:
Assiut University
Conditions:
Hodgkin Lymphoma
Eligibility:
All Genders
18-75 years
Brief Summary
determine the early toxicity and loco-regional control comparing outcome of radiothrapy rither by using INRT or IFRT in treatment of early stage hodgkin lymphoma determine progression-free survival a...
Detailed Description
Hodgkin lymphoma (HL) is one of the most frequent lymphomas in the Western world, with an annual incidence of about 3 cases per 100,000 persons. This lymphoid malignancy involves peripheral lymph node...
Eligibility Criteria
Inclusion
- Histologically proven Hodgkin's Lymphoma, with exclusion of the nodular lymphocyte predominant subtybe
- Clinical stage I or II, only supra-diaphragmatic nodes, both favorable and unfavorable prognostic subsets
- Previously untreated.
- Age: between 18 and 75 years.
- Good general condition(WHO performance status 0-2).
- Free of concurrent disease.
Exclusion
- Patients with impaired heart, lung, liver, or kidney function.
- Previous malignant diseases or HIV-positive status
- Patient with advanced or infra-diaghragmatic Hodgkin's disease
- Pregnant or lactating women
- Patient with prior irradiation to the neck and thorathic region
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05284396
Start Date
May 1 2022
End Date
October 1 2025
Last Update
March 17 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.